Although genotoxic chemotherapeutic drugs effectively kill cancer cells by inducing deleterious DSBs, it is widely recognized that high levels of MYC eventually render cancer cells resistant to genotoxic drugs [117]. This evidence concerns the gene MYC and cancer.